Fabio Lopez Net Worth

What's Fabio Lopez's mailing address?

Fabio's mailing address filed with the SEC is EQUILIBRIA CAPITAL MANAGEMENT LTD., ONE BERMUDIANA ROAD, HAMILTON, D0, HM08.

Insiders trading at SELLAS Life Sciences Inc

Over the last 7 years, insiders at SELLAS Life Sciences Inc have traded over $74,616 worth of SELLAS Life Sciences Inc stock. The most active insiders traders include John Varian, Jane Wasman és David A Scheinberg. On average, SELLAS Life Sciences Inc executives and independent directors trade stock every 205 days with the average trade being worth of $6,842. The most recent stock trade was executed by Angelos M. Stergiou on 5 December 2022, trading 6,494 units of SLS stock currently worth $16,949.

What does SELLAS Life Sciences Inc do?

σellas life sciences is a healthcare-oriented global group of companies with a unique and innovative vision, which is ambitious, yet clear: to practice the medicine of tomorrow, today. in other words, we incorporate innovation throughout all our activities aiming at breakthroughs that will have a significant impact on the thinking and practicing of healthcare worldwide. our international team of acknowledged scientists, doctors and health professionals along with a seasoned and highly experienced pharmaceutical executive management form the core of σellas. we strive to improve patients' quality of life through developing and commercializing cutting-edge drugs, medical devices and innovative therapies.

SELLAS Life Sciences Inc executives and stock owners

SELLAS Life Sciences Inc executives and other stock owners filed with the SEC include:

• Angelos Stergiou,
  President, Chief Executive Officer, Director
• Dr. Angelos M. Stergiou M.D., ScD h.c.,
  Founder, Pres, CEO & Director
• Barbara Wood,
  Executive Vice President, General Counsel, Corporate Secretary
• Barbara A. Wood,
  Exec. VP, Gen. Counsel & Sec.
• Dr. Dragan Cicic M.D., MBA,
  Sr. VP of Clinical Devel.
• John Burns,
  Interim Principal Accounting Officer, Vice President - Finance, Corporate Controller
• Dr. Dragan Cicic,
  Sr. VP of Clinical Devel.
• Jane Wasman,
  Independent Chairman of the Board
• John Varian,
  Independent Director
• Robert Van Nostrand,
  Independent Director
• David Scheinberg,
  Director
• Dragan Cicic,
  Senior Vice President - Clinical Development
• Jörg W. Breitkopf,
  Head of Clinical Operations
• Robert M. Francomano,
  Sr. VP & Chief Commercial Officer
• John Thomas Burns CPA,
  Sr. VP of Fin. & Chief Accounting Officer
• David D. Moser,
  VP of Legal Affairs
• Jörg W. Breitkopf,
  Head of Clinical Operations
• Dr. Christopher R. Shackleton,
  Director of Clinical and Bus. Operations
• Martin G. Baum,
  Chief Operating Officer
• John Thomas Burns CPA, CPA,
  VP of Fin., Corp. Controller & Chief Accounting Officer
• Fabio Lopez,
  Director
• Nicholas J. Sarlis,
  Chief Medical Officer and SVP
• Robert Francomano,
  Chief Commercial Officer
• Fabio Eqc Private Markets S...,
  
• Stephen F Ghiglieri,
  Director
• Gregory M Torre,
  CRO and SVP
• Fabio Eqc Private Markets S...,
  
• Gene Mack,
  CFO and Treasurer
• Katherine Bach Kalin,
  Director